AST SpaceMobile Downgrade Sparks Concern

AST SpaceMobile downgrade after Piper Sandler cut its target, citing launch pace doubts and SpaceX competition, tightening trader positioning.

October 13, 2026·1 min read
View all news articles
Flat-vector dimming satellite symbolizing AST SpaceMobile downgrade and launch-cadence concerns on a light gradient.

KEY TAKEAWAYS

  • Piper Sandler cut AST SpaceMobile to Neutral and trimmed its target to $54 from $98, about 45%.
  • Cited lower conviction in the near-term launch cadence, raising re-rating risk for execution-dependent valuation.
  • Reports linked the call to SpaceX direct-to-cell competition while at least one other sell-side firm remained bullish.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

AST SpaceMobile’s downgrade on Oct. 13, 2026, followed Piper Sandler’s reduction of its price target and lowered confidence in the company’s satellite-launch pace for 2026–2027, refocusing investor attention on competition from SpaceX.

Piper Sandler Downgrade and Launch Concerns

Piper Sandler downgraded AST SpaceMobile from Overweight to Neutral and cut its price target by about 45%, to $54 from $98. The firm cited reduced conviction in the company’s satellite-launch cadence as the main reason for the change. This shift highlights near-term re-rating risk by placing execution—specifically the speed of satellite deployments—at the center of valuation debates that had assumed a faster buildout.

SpaceX Competition and Divergent Analyst Views

Reports linked the downgrade partly to SpaceX’s expanding direct-to-cell ambitions, which pose a competitive threat to satellite-to-cell providers. However, no primary SpaceX filings or detailed Piper Sandler analysis were available to clarify how much competition influenced the call versus execution concerns.

Meanwhile, at least one other major sell-side firm reportedly maintained or raised a Buy rating on AST SpaceMobile, indicating a split among analysts. This divergence sharpens investor focus on whether the company can accelerate launches and clarify commercial rollout plans—key factors underpinning previous valuations and investor confidence.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Bank of America Penalty Draws Treasury Action

Bank of America Penalty Draws Treasury Action

Bank of America penalty of more than $1.21 billion from Treasury agencies highlights alleged AML reporting failures traders will weigh for regulatory risk.

OpenAI Employee Arrested Over Hidden Recording Device

OpenAI Employee Arrested Over Hidden Recording Device

OpenAI employee arrested after a hidden device was discovered; company says models identified installer and found no data loss easing investor risk.

Cipher Digital Convertible Notes Proposal Sends Shares Lower

Cipher Digital Convertible Notes Proposal Sends Shares Lower

Cipher Digital convertible notes proposal would raise $850 million and include a concurrent exchange, raising dilution concerns and pressuring shares.

Character.AI Bankruptcy Draws Disney Interest

Character.AI Bankruptcy Draws Disney Interest

Character.AI bankruptcy starts a Section 363 sale with Disney as stalking-horse and $20 million bid, compressing the auction and shaping recoveries.

Six Flags Over Georgia Incident Prompts Ride Closures

Six Flags Over Georgia Incident Prompts Ride Closures

Six Flags Over Georgia incident triggered precautionary coaster closures and state reviews, raising near-term operational risk to attendance and shares.

Johnson & Johnson Q3 2026 Earnings Rise, MedTech Lags

Johnson & Johnson Q3 2026 Earnings Rise, MedTech Lags

Johnson & Johnson Q3 2026 earnings raised guidance to a $101.2 billion sales midpoint while MedTech weakness may force traders to reprice device risk.